Taking into account the ability of apoA-I to protect MSCs under H2O2-induced oxidation, we wondered whether apoA-I addition to improve the reduced antioxidant properties of blood plasmas of T2D patients in the conditions of oxidation. Here, APOA1 is linked to type 2 diabetes mellitus.